Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Bioadaptives (BDPT) Return on Capital Employed (2019 - 2025)

Bioadaptives' Return on Capital Employed history spans 7 years, with the latest figure at 0.48% for Q4 2025.

  • Quarterly results put Return on Capital Employed at 0.48% for Q4 2025, up 9.0% from a year ago — trailing twelve months through Dec 2025 was 0.48% (up 9.0% YoY), and the annual figure for FY2025 was 0.49%, up 10.0%.
  • Return on Capital Employed for Q4 2025 was 0.48% at Bioadaptives, down from 0.81% in the prior quarter.
  • In the past five years, Return on Capital Employed ranged from a high of 0.81% in Q3 2025 to a low of 0.11% in Q2 2023.
  • The 5-year median for Return on Capital Employed is 0.33% (2021), against an average of 0.36%.
  • The sharpest move saw Return on Capital Employed crashed -34bps in 2023, then skyrocketed 66bps in 2025.
  • Year by year, Return on Capital Employed stood at 0.59% in 2021, then plummeted by -51bps to 0.29% in 2022, then plummeted by -49bps to 0.15% in 2023, then skyrocketed by 157bps to 0.38% in 2024, then grew by 25bps to 0.48% in 2025.
  • According to Business Quant data, Return on Capital Employed over the past three periods came in at 0.48%, 0.81%, and 0.81% for Q4 2025, Q3 2025, and Q2 2025 respectively.